DexCom, Inc. (NASDAQ:DXCM)

CAPS Rating: 1 out of 5

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.

Results 1 - 20 of 25 : 1 2 Next »

Recs

0
Member Avatar Flygal5 (99.00) Submitted: 6/4/2014 6:12:48 PM : Outperform Start Price: $35.54 DXCM Score: +10.38

Teaming with Appl gives me faith in the future of this approved distance glucose monitor ans app

Recs

0
Member Avatar TerryFool (< 20) Submitted: 2/25/2014 10:02:24 AM : Outperform Start Price: $39.91 DXCM Score: -6.48

DXCM BP 40 TP 44 REV 1yr 60% EPS 1yr 400%

Recs

0
Member Avatar jachristy (35.78) Submitted: 2/4/2014 9:21:34 AM : Outperform Start Price: $41.03 DXCM Score: -15.38

I think they'll get bought out at some point.

Recs

0
Member Avatar Jonock (< 20) Submitted: 10/16/2013 6:22:49 AM : Outperform Start Price: $29.66 DXCM Score: +19.15

Growth Stock

Recs

0
Member Avatar TMFHumbleServant (96.43) Submitted: 3/11/2013 8:32:08 AM : Outperform Start Price: $15.75 DXCM Score: +126.41

Designs continuous glucose monitoring systems.

Recs

0
Member Avatar halarts (< 20) Submitted: 6/14/2012 1:35:03 PM : Outperform Start Price: $12.31 DXCM Score: +176.08

I am a type II diabetic and I have used both the DXCM and MDT continuous glucose monitors and the DXCM one is more comfortable and more accurate than the MDT version. Insurance companies began coverage for these units over the last year and that should have a significant impact on sales.

On top of all that -- it makes a difference on how well I control my blood sugars and on doing analysis on the data to determine proper insulin levels.

Recs

0
Member Avatar twiggy126 (75.19) Submitted: 3/21/2011 3:28:21 PM : Outperform Start Price: $14.23 DXCM Score: +128.24

It's daily life improving potential for diabetics

Recs

0
Member Avatar derbygirl (53.17) Submitted: 11/9/2010 1:31:39 PM : Outperform Start Price: $11.76 DXCM Score: +177.80

Dexcom has been an innovator in continuous glucose monitoring. Their product is accurate and more comfortable to wear than their competitor. Their only delay in producing a closed loop system in the US for diabetes control has to do with new FDA requests. Their closed loop system will debut in Europe next year. Their partnerships with pump manufacturers and their R & D push will put them over the top in diabetes management. News of FDA delays have pushed the stock down, but only temporarily.

Recs

0
Member Avatar TMFTypeoh (80.08) Submitted: 11/8/2010 8:57:37 AM : Outperform Start Price: $10.78 DXCM Score: +208.96

purely speculation.......don't put real money here.

They will continue to lose money for a while, but their technology is real, and the bet here is on a takeover (most likely JNJ).

FDA hammered them this week....probably over done.

Check them out as LEAPS maybe.......

Recs

0
Member Avatar franktejon (< 20) Submitted: 11/6/2010 4:21:43 PM : Outperform Start Price: $10.78 DXCM Score: +208.96

strong bu for daily trading

Recs

0
Member Avatar AnotherDumbFool (< 20) Submitted: 2/15/2010 4:13:26 PM : Outperform Start Price: $9.75 DXCM Score: +228.11

DexCom's focus with it's glucose sensor is arguably the best in it's field also its partnership with J&J's Animas Corp. shows real promise.

Recs

1
Member Avatar plaws213 (95.21) Submitted: 6/16/2009 10:03:31 AM : Outperform Start Price: $6.50 DXCM Score: +400.05

Who wants to prick their finger six times a day?

Recs

0
Member Avatar cpalerm (81.85) Submitted: 3/21/2009 6:51:19 PM : Outperform Start Price: $4.32 DXCM Score: +670.41

Dexcom has entered into several agreements that will help it expand its market share.

Recs

0
Member Avatar ardys13 (< 20) Submitted: 2/9/2009 3:25:48 PM : Outperform Start Price: $3.70 DXCM Score: +848.28

ripe for acquisition

Recs

7
Member Avatar BiLoandWise (26.61) Submitted: 5/4/2008 7:56:01 PM : Underperform Start Price: $7.28 DXCM Score: -403.00

Their devices haven't been selling, their financials are awful, the stock price has been plummeting and they're headed toward bankruptcy.

Recs

0
Member Avatar BonusCash (< 20) Submitted: 5/3/2008 5:43:29 PM : Underperform Start Price: $7.28 DXCM Score: -403.00

This is due for a correction from the recent run.

Recs

0
Member Avatar Emhfool (96.88) Submitted: 4/24/2008 12:03:26 PM : Underperform Start Price: $7.26 DXCM Score: -401.04

Check this scenario out:

Would you want to own a company with a 200m market cap, 4.6m in revenue in a highly competitive landscape?

I'm a slacker, check this research:
Go to your web browser, and enter "diabetes glucose monitoring system".

I got 750,000 hits which was enough to convince me that this technology is not even close to unique. Your buying an idea, one that is already been thought of mind you, and not a company.

Recs

0
Member Avatar Dapperatom (< 20) Submitted: 4/24/2008 11:04:42 AM : Outperform Start Price: $7.30 DXCM Score: +397.71

I like the below $10 price and its potential for a good return.

Recs

0
Member Avatar handoverhill (< 20) Submitted: 4/21/2008 7:16:05 AM : Outperform Start Price: $6.83 DXCM Score: +436.22

This stock will being doing good on the market for the next several months because it has a good market and the profits show us that and the market is starting to pick up.

Recs

0
Member Avatar skc0001 (< 20) Submitted: 6/18/2007 3:10:07 AM : Outperform Start Price: $6.82 DXCM Score: +449.58

Proposed by Good People

Results 1 - 20 of 25 : 1 2 Next »

Featured Broker Partners


Advertisement